Literature DB >> 1958077

Therapeutic abilities of thiol compounds in the restoration of methylmercury-inhibited cholesterol and triglycerides of the rat's central nervous system.

P P Sood1, S D Vinay.   

Abstract

The present study was basically designed to gain an insight into the alterations in the levels of cholesterol and triglycerides in various neuroanatomical areas of the rat under the influence of different doses and durations of methylmercury chloride (MMC), N-acetyl-DL-homocysteine thiolactone (NAHT), and glutathione (GSH) applications. The study showed insignificant alterations in the levels of both the metabolites after two days of drug and antagonist application. The rest of the animal groups exhibited a progressive inhibition of both the metabolites in all the CNS areas with increasing dose and duration of drug treatment. The antagonists, NAHT and GSH, were able to cause a recovery in both the metabolites in most of the groups, yet in no case were absolute control values achieved. It was concluded that antagonists alone are not helpful in mobilizing the mercury as well as producing a recovery in the biochemical lesions induced in the CNS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958077     DOI: 10.1007/bf01055339

Source DB:  PubMed          Journal:  Arch Environ Contam Toxicol        ISSN: 0090-4341            Impact factor:   2.804


  17 in total

1.  Distribution of dietary mercury in a dog. Quantitation and localization of total mercury in organs and central nervous system.

Authors:  J C Hansen; E Reske-Nielsen; O Thorlacius-Ussing; J Rungby; G Danscher
Journal:  Sci Total Environ       Date:  1989-01       Impact factor: 7.963

2.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

3.  Experimental organic mercury poisoning--regeneration of peripheral nerves.

Authors:  T Miyakawa; M Deshimaru; S Sumiyoshi; A Teraoka; S Tatetsu
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

4.  Effects of complexing treatment administered with the onset of methyl mercury neurotoxic signs.

Authors:  L Zimmer; D E Carter
Journal:  Toxicol Appl Pharmacol       Date:  1979-10       Impact factor: 4.219

5.  Methylmercuric chloride and serum cholesterol level in the bluegill (Lepomis macrochirus).

Authors:  H M Dutta; A Z Haghighi
Journal:  Bull Environ Contam Toxicol       Date:  1986-02       Impact factor: 2.151

6.  The interaction of mercurials with myelin: comparison of in vitro and in vivo effects.

Authors:  A L Ganser; D A Kirschner
Journal:  Neurotoxicology       Date:  1985       Impact factor: 4.294

7.  Biochemical changes resulting from the intraperitoneal administration of mercuric chloride and methylmercuric chloride to mice.

Authors:  M Mehra; K C Kanwar
Journal:  Toxicol Lett       Date:  1980-09       Impact factor: 4.372

8.  Abnormalities in gangliosides and other lipids of monkey, rabbit and human brains with chronic organic mercury intoxication.

Authors:  S Ando; Y Toyoda; Y Nagai; F Ikuta
Journal:  Jpn J Exp Med       Date:  1985-02

9.  Ultramicro determination of serum triglycerides by bioluminescent assay.

Authors:  M Werner; D G Gabrielson; J Eastman
Journal:  Clin Chem       Date:  1981-02       Impact factor: 8.327

10.  Compositional changes in brain lipids, especially cerebroside and gangliosides, of rats treated with methylmercury chloride.

Authors:  S Ando; Y Toyoda; Y Nagai; S Nakashima; S Abe; F Ikuta
Journal:  Jpn J Exp Med       Date:  1985-02
View more
  2 in total

1.  Multiresponse biomarker evaluation of interactions between methylmercury and Arochlor 1260 in quail.

Authors:  C Leonzio; F Monaci; M C Fossi; L Lari; N Mattei; S Corsolini
Journal:  Ecotoxicology       Date:  1996-12       Impact factor: 2.823

Review 2.  The influence of nutrition on methyl mercury intoxication.

Authors:  L Chapman; H M Chan
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.